The outbreak of COVID-19 has affected each of us in many ways. In clinical trials, site visits by patients, CRAs and site personnel have been severely restricted or cancelled. This fast-changing situation has led us to re-evaluate how we adapt our monitoring models to continue to help our customers bring potential healthcare treatments to patients.
Join this timely and insightful webinar to understand how we are coordinating with local health authorities and customers to deploy, when appropriate, our services and technologies to further increase remote-based CRA and Centralized monitoring for trials, remote patient visits (aka virtual trials), supply logistics and other remote interactions between patients and HCPs to enable study continuity on a global basis.
Learn how the use of technology and innovative approaches is keeping clinical trials on track while enhancing the safety and quality of those involved by automating digital processes, including:
- Delivering transformative tools like IQVIA COVID Active Research Experience (CARE) Project and COVID-19 Trial Matching Solution
- Utilizing IQVIA's virtual trials execution platform Study Hub to enable televisits and eDiary
- Rapidly implementing remote and risk-based monitoring principles
- Conducting active/on-going risk assessment and mitigation exercises
Register today and hear how companies are transforming their processes and driving continuity in their clinical development efforts!